Approved by the FDA in 1993, the drug cladribine offered hope for the then-fatal blood cancer called hairy cell leukemia, or HCL, and was soon expanded as a therapy for multiple sclerosis. Developed by NFCR scientist Dr. Dennis Carson at the University of California, San Diego, cladribine acts like a…...
Childhood Cancer Awareness Month: Ella’s Story
For all of the celebrations that come with parenthood, there are also many unique challenges. Though these challenges differ from one family to another, all parents share the ultimate goal of keeping their children healthy and happy. September, nationally recognized as Childhood Cancer Awareness Month, shines a spotlight on one…...
Genetic Cues to Ovarian Cancer Explored
September is Ovarian Cancer Awareness Month, highlighting a disease that kills nearly 15,000 women annually out of the 21,000 diagnosed. Relatively uncommon as cancers go, ovarian cancer nevertheless causes the most deaths from all gynecological cancers. Known as the “silent killer”, Ovarian Cancer presents no symptoms at all, or symptoms…...
The Hallmarks of Metastasis
It is the one word you do not want to hear in a cancer diagnosis: metastasis. It represents the figurative death-knell; once a cancer has spread to other parts of the body, survival rates plummet and what treatments do exist switch from curative to palliative. The dividing line metastatic cancer…...
New Combination Therapy Improves Pancreatic Cancer Survival
A new combination of two standing drugs and radiation therapy has the potential to revolutionize the treatment and care of pancreatic cancer, one of the most lethal diagnoses an oncologist can face with patients. Using data from studies by NFCR fellow Dr. Rakesh Jain, investigators at Massachusetts General Hospital used…...
How Cancer Kick-Started a Lymphoma Survivor’s Business Idea
When a loved one is diagnosed with cancer, friends and family want to do something to show their support and care for the patient. This often includes sending flowers, a card or cooking meals for the patient and their family. Unfortunately, many patients are immunosuppressant while going through cancer and…...
Strategic Media Partner
